Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients [Phase 1]
Phase 1 study evaluating BHQ880 in combination with zoledronic acid in relapsed or refractory multiple myeloma with bone disease has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma [Phase 1]
Phase 1 trial evaluating stem cell mobilization with plerixafor and filgrastim after cyclophosphamide in patients with multiple myeloma has …
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]
A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hema…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1]
Phase 1 trial of panobinostat in combination with everolimus for relapsed or refractory lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Bevacizumab and Bortezomib in Patients With Advanced Malignancy [Phase 1]
This Phase 1 trial evaluated the combination of Bevacizumab and Bortezomib in patients with advanced malignancies, including lymphoma, multi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]
This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating vorinostat in combination with bortezomib for relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Phase 1, Phase 2]
This clinical trial update indicates termination of a Phase 1/2 study evaluating arsenic trioxide with or without tretinoin in patients with…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure [Phase 1]
A Phase 1 study evaluating combined bone marrow and kidney transplantation for patients with multiple myeloma and chronic kidney disease has…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis [Phase 2]
A Phase 2 clinical trial investigated chemotherapy plus peripheral stem cell transplant in patients with multiple myeloma or primary systemi…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease [Phase 2]
Phase 2 trial evaluating suramin for refractory or relapsed multiple myeloma or Castleman's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Phase 1]
A Phase 1 trial evaluating paricalcitol with zoledronate in relapsed or refractory multiple myeloma and other plasma cell disorders was term…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma [Phase 2]
Phase 2 clinical trial update evaluating chemotherapy, stem cell transplantation, and donor/patient vaccination strategies for multiple myel…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant [Phase 2]
Phase 2 clinical trial evaluating reduction of immunosuppression plus interferon alfa and chemotherapy for post-transplant malignant tumors;…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib-Dexamethasone-Doxorubicin-Study [Phase 2]
A Phase 2 clinical trial evaluating the combination of bortezomib, dexamethasone, and doxorubicin in patients with multiple myeloma and rena…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating flavopiridol in relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of 2-methoxyestradiol in patients with refractory or stage III multiple myeloma and other advanced solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Bryostatin and Vincristine in B-Cell Malignancies [Phase 1]
Phase 1 trial evaluating Bryostatin-1 in combination with Vincristine in several recurrent or refractory B-cell malignancies; the study has …
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse [Phase 2]
This update confirms the completion of a Phase 2 study evaluating bortezomib plus dexamethasone for relapsed multiple myeloma, with a mainte…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of sorafenib for relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma [Phase 1]
A completed Phase 1 study evaluating arsenic trioxide with pamidronate in patients with advanced solid tumors or refractory multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]
Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Trial of Romidepsin and Bortezomib for Multiple Myeloma [Phase 2]
Phase 2 trial of romidepsin plus bortezomib in multiple myeloma was terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma [Phase 1, Phase 2]
The study evaluated the safety and efficacy of P276-00 in relapsed and/or refractory multiple myeloma across Phase 1 and Phase 2 and has com…